Home/Filings/4/0001209191-23-055843
4//SEC Filing

Virani Shafique 4

Accession 0001209191-23-055843

CIK 0001601830other

Filed

Nov 16, 7:00 PM ET

Accepted

Nov 17, 5:52 PM ET

Size

15.1 KB

Accession

0001209191-23-055843

Insider Transaction Report

Form 4
Period: 2023-11-15
Virani Shafique
Chief Corp. Dev. Officer
Transactions
  • Tax Payment

    Class A Common Stock

    2023-11-15$7.18/sh3,603$25,870136,748 total
  • Exercise/Conversion

    Class A Common Stock

    2023-11-15$2.22/sh+18,000$39,960158,351 total
  • Sale

    Class A Common Stock

    2023-11-15$6.51/sh18,000$117,180140,351 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-11-1518,000397,469 total
    Exercise: $2.22Exp: 2030-03-03Class A Common Stock (18,000 underlying)
Holdings
  • Stock Option (Right to Buy)

    Exercise: $11.40Exp: 2032-02-04Class A Common Stock (0 underlying)
    80,450
  • Stock Option (Right to Buy)

    Exercise: $8.55Exp: 2033-02-01Class A Common Stock (0 underlying)
    212,507
  • Stock Option (Right to Buy)

    Exercise: $11.40From: 2022-02-04Exp: 2032-02-04Class A Common Stock (0 underlying)
    5,436
Footnotes (5)
  • [F1]Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023.
  • [F2]Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.
  • [F3]The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
  • [F4]One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 1, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date. 704,955 shares were originally subject to this stock option upon the grant date.
  • [F5]The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.

Issuer

RECURSION PHARMACEUTICALS, INC.

CIK 0001601830

Entity typeother

Related Parties

1
  • filerCIK 0001856081

Filing Metadata

Form type
4
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 5:52 PM ET
Size
15.1 KB